[1] Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease(TASC II)[J]. Eur J Vasc Endovasc Surg, 2007, 33 Suppl 1:S1-75. [2] Lowe GD. Venous and arterial thrombosis: epidemiology and risk factors at various ages[J]. Maturitas, 2004, 47:259-263. [3] Curtis C, Ogbogu P. Hypereosinophilic syndrome[J]. Clin Rev Allergy Immunol, 2016, 50:240-251. [4] Requena G, Logie J, Gibbons DC, et al. The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom[J]. Immun Inflamm Dis, 2021, 9:1447-1451. [5] 韩迎东,王嵩,韩欣欣,等. 25例伴外周动脉闭塞的嗜酸性粒细胞增多症患者临床特点分析[J]. 基础医学与临床,2023,43:785-789. [6] Takeuchi H, Kawamura K, Kawasaki T, et al. Distinct features of hypereosinophilic syndrome with neuropathy from eosinophilic granulomatosis with polyangiitis[J]. Front Neurol, 2022, 13:1057767. doi: 10.3389/fneur.2022. [7] Ackerman SJ, Bochner BS. Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders[J]. Immunol Allergy Clin North Am, 2007, 27:357-375. [8] Moosbauer C, Morgenstern E, Cuvelier SL, et al. Eosinophils are a major intravascular location for tissue factor storage and exposure[J]. Blood, 2007, 109:995-1002. [9] Kanno H, Ouchi N, Sato M, et al. Hypereosinophilia with systemic thrombophlebitis[J]. Human pathology, 2005, 36:585-589. [10] 宋小军,刘昌伟. 特发性嗜酸性粒细胞增多症累及周围血管治疗体会[J]. 临床外科杂志, 2008, 16:778-779. [11] 胡海地,常青,陈喆,等. 急性肢体动脉栓塞患者的外科诊治及预后分析[J]. 中华医学杂志, 2011, 91:2923-2926. [12] Klion A. Hypereosinophilic syndrome: current approach to diagnosis and treatment[J]. Annu Rev Med, 2009, 60:293-306. |